According to its latest trading records, ARK Invest trimmed its BYD position by 219,468 shares through its ARKQ Automation & Robotics ETF on Friday, November 13, with the transaction valued at $1.865 million. Simultaneously, ARK added 24,784 shares of Kratos Defense & Security Solutions (KTOS-US) for approximately $861,000 through the same fund, continuing its recent boost to defense holdings. In biotech, ARK's ARKG Genomic Revolution ETF purchased 28,905 shares of Scribe Therapeutics (SCTX-US) for roughly $491,000, extending its week-long buying streak in the stock.

View Source

Disclaimer: This content is for informational purposes only and does not constitute investment advice or encourage the buying or selling of crypto assets. It is intended to provide information about industry developments and is not directly related to the services offered by Gate TR. Although information obtained from third-party sources has been carefully reviewed, Gate TR assumes no responsibility for any errors or omissions. Crypto assets involve high risks and may experience significant price fluctuations. Before making any investment decisions, you should assess your financial situation and risk tolerance, conduct your own research, and make decisions independently.